iMed.ULisboa leads the FCT PhD Programme in Medicines and Pharmaceutical Innovation (i3DU) at FF/ULisboa. Other FCT funded PhD Programmes are also supported by iMed.ULisboa, including the Medical Biochemistry and Biophysics Doctoral Programme (M2B-PhD) and the PhD Program in Integrative Neuroscience (NeurULisboa) at FM/ULisboa, the Medicinal Chemistry PhD Programme (MedChemTrain) at University of Coimbra, and the Doctoral Programme in Advanced Integrated Microsystems (AIM) at IST/ULisboa. Currently, ca. 100 PhD students pursue post-graduate training at iMed.ULisboa, mainly supported by doctoral degree grants from FCT or by doctoral degree grants in partnership with pharmaceutical industry.
iMed.ULisboa integrates also large consortium initiatives, such as the pan-European Education and Training Programmes SafeSciMET and PharmaTrain for pharmaceutical medicines and drug safety funded by the European Innovative Medicines Initiative (IMI), a joint undertaking of the European Commission and European Federation of Pharmaceutical Industries and Associations, bringing together many top universities/institutes and pharmaceutical industry. Other participations include the ULisboa funded initiatives Mind-Brain College of ULisboa and Colégio F3 Food, Farming and Forestry.